Diversified fund project of the Natural Science Foundation of Tianjin, China [grant number 21JCQNJC01240]
doi: 10.4012/dmj.2023-166 22 Fiegler-RudolJ.KaponK.KotuchaK.MoM.SkabaD.Kawczyk-KrupkaA.et al
Parenteral administration of minute amounts of endotoxins to humans elicits an inflammatory reaction typical of SIRS (fever or hypothermia, tachycardia, hyperpnea, leukocytosis, and hypotension), whereas larger amounts of administered endotoxins typically produce sepsis and shock [66, 67]
Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, Wilding G, Pomplun M, Spriggs DR: Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione